Publicly Traded

  1. You are here:    Home
  2. Analytics
  3. Publicly Traded

Alert!

To view the full data details, please   Login  or   Register.
 
Intellectual Property
  Explanation

Synopsis: SBIR-STTR IPO Data

Publicly Traded Firms
1,002
Prog Active Firms
103
SBIR-STTR Awards
7,846
SBIR-STTR Dollars
$3.3B
VC Dollars
$101.2B
IPO+ Dollars
$96.8B
  Explanation

SBIR Index (Weekly indicator)

SBIR Index
14.29%
04/26/2024
73 firms
Developed and maintained by Innovation Development Institute, LLC., the SBIR Index is a regularly updated indicator carried here on the site. The calculation is based on the weekly, close-of-business share price of those firms which are currently Publicly Traded and which have been and/or still are SBIR-involved.
  Explanation

Distribution of SBIR Public Firms By State

0 1 - 9 10 - 24 25 - 99 100+
  Explanation

By Agency Distribution of SBIR Public Firms

  Explanation

Firms by Stock Exchange

  Explanation

SBIR M&A by Price Paid: Public Firms vs Private

  Explanation

Featured SBIR Firm

Xeris Pharmaceuticals Inc
Publicly traded since June 2018, Xeris Pharmaceuticals (NASDAQ:XERS) is a specialty pharmaceutical company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology. With a novel technology platform that enables re... see more
www.xerispharma.com | (844) 445-5704
  Explanation

SBIR Publicly Traded News

Aug 22 2023
Grander Closes Acquisition of PolarityTE, Inc. Assets
Apr 28 2023
Pfizer Buys Lucira Health for $36.4M Through Bankruptcy Auction
Apr 12 2023
PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its Assets
Jan 27 2023
RealNetworks, Inc. ("Real") completed a "going private" merger transaction
Sep 23 2022
CytRx Corporation Relaunches as LadRx Corporation
  Explanation